Market research
EHC Encompass Health Corp
NYSE USD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 12B
- P/E ratio
- 20.42
- Analyst target
- 148.1667
- Dividend yield
- 0.6%
- Beta
- 0.6
Profile
Instrument facts
- Exchange
- NYSE
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- Not available
- Market cap
- 12B
- P/E ratio
- 20.42
- Analyst target
- 148.1667
- Dividend yield
- 0.6%
- Beta
- 0.6
About
About Encompass Health Corp
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
Research context
Encompass Health Corp appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the EHC discussion.
5 years, 6 months ago
Encompass Health Corporation is currently in a long term uptrend where the price is trading 1.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
Encompass Health Corporation's total revenue rose by 2.5% to $1B since the same quarter in the previous year.
Its net income has increased by 27.2% to $86M since the same quarter in the previous year.
Finally, its free cash flow grew by 65.5% to $133M since the same quarter in the previous year.
Based on the above factors, Encompass Health Corporation gets an overall score of 5/5.